Results 271 to 280 of about 31,607 (347)

Bridging the gap: the role of large language model refinement in readability in urology research

BJU International, EarlyView.
Giovanni E. Cacciamani, Ethan Layne, Maria Giovanna Asmundo, Giorgio Ivan Russo   +3 more
wiley   +1 more source

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra‐operative detection and translational research

BJU International, EarlyView.
Objectives To review the clinical utility, outcome and possible future applications of sentinel lymph node biopsy (SLNB) in penile cancer (PeC), bladder cancer (BCa), prostate cancer (PCa), testicular cancer (TCa) and renal cell carcinoma (RCC), focusing in particular on current SLNB standards and exploring advancements in imaging agents, intra ...
Erik J. van Gennep, Gijs H. KleinJan, Teele Kuusk, Rick W.A. Verdijk, Esther M.K. Wit, Bas W.G. van Rhijn, Axel Bex, Laura S. Mertens   +7 more
wiley   +1 more source

Outcomes in children with vesicoureteral reflux receiving antibiotic prophylaxis. [PDF]

Antimicrob Steward Healthc Epidemiol
Tompkins MG, Kussin M, Christenson JC, Boyd L, Tat K, Schneider JG, Han RT.   +6 more
europepmc   +1 more source

Impact of timing of computed tomography staging and patient factors on the detection of ‘true’ cN+ bladder cancer

BJU International, EarlyView.
Objectives To evaluate whether computed tomography (CT) scans should be performed before or after transurethral resection of bladder tumour (TURBT) for accurate lymph node staging in clinically lymph node‐positive bladder cancer (BCa). Additionally, to identify patient factors that can aid in predicting lymph node metastasis.
Markus von Deimling, Marc Furrer, Alberto Bianchi, Renate Pichler, Moritz Maas, Karl H. Tully, Mattia Longoni, Laura S. Mertens, Jacob Taylor, Francesco del Giudice, Roger Li, Andrea Gallioli, Simone Albisinni, Felice Crocetto, Maud Velev, Luca Afferi, Andrea Mari, Ekaterina Laukhtina, Jakob Klemm, Nirmish Singla, Margit Fisch, Philippe E. Spiess, Yair Lotan, Marco Moschini, Peter C. Black, Alessandro Antonelli, Bernhard Kiss, Shahrokh F. Shariat, Benjamin Pradere, CLIPOLY study group collaborators, Luca Antonelli, Mara Bacchiani, Ronan Flippot, Abhinav Khanna, Elisabeth Maier, Gautier Marcq, Andrea Minvervini, Keiichiro Mori, Maximilian Pallauf, Nicolas Penel, Julien Sarkis, Francesco Soria, Guus A.H. Tendijck, Noor van Ginkel, Solomon Woldu   +44 more
wiley   +1 more source

Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide

BJU International, EarlyView.
Objectives To evaluate the longitudinal transcriptomic changes that occurred over time in patients from the ENACT trial (ClinicalTrials.gov identifier: NCT02799745). ENACT evaluated patients with low‐ or intermediate‐risk prostate cancer, comparing the efficacy and safety of enzalutamide plus active surveillance (AS) to AS alone.
Nicole Handa, Neal D. Shore, Matthew R. Cooperberg, Elai Davicioni, Xin Zhao, Dina Elsouda, Yang Liu, James A. Proudfoot, Gaston Kuperman, David Russell, Kenneth K. Iwata, Edward M. Schaeffer, Ashley Ross   +12 more
wiley   +1 more source

Editorial: Genomic discoveries and pharmaceutical development in urologic tumors. [PDF]

Front Pharmacol
Meng J, Yang H, Yin L.
europepmc   +1 more source

Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate‐risk prostate cancer

BJU International, EarlyView.
Objective To provide a comprehensive review and analysis of guidelines from various professional and medical organisations regarding the use of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) as a staging scan for men with newly diagnosed intermediate‐risk prostate cancer (PCa).
Jonathon Carll, Weiwei Shi, Marlon Perera, Nathan Lawrentschuk, Thilakavathi Chengodu, Dixon Woon   +5 more
wiley   +1 more source

Urologic Diseases in Elderly Men

Journal of the Korean Medical Association, 2005
openaire   +2 more sources

What has the COVID‐19 pandemic taught us about safety of surgical wait times in urological oncology?

BJU International, EarlyView.
Objectives To review papers assessing the impact of surgical delay in relation to the COVID‐19 pandemic, and evaluate what has been learnt about the safety of surgical waiting times in urological oncology. Patients and Methods Medline and Web of Science were searched for studies published between 1 January 2020 and 1 November 2024.
James P. Blackmur, Chiara Re, Grant D. Stewart   +2 more
wiley   +1 more source